Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Sailesh Raj Bhan, Kinjal Desai. The fund could potentially beat inflation in the long-run.
1) Nippon India Pharma Fund - Direct Plan - Growth Plan has a NAV of ₹304.0983 as on 17-08-2022.
2) Nippon India Pharma Fund - Direct Plan - Growth Plan has ₹4620 Cr worth of assets under management (AUM) as on 30-06-2022 and is more than category average.
3) The fund has an expense ratio 1.06 %.
Expense ratio | 1.06% |
Benchmark | S&P BSE Healthcare PR |
AUM | ₹4620 Cr |
Inception Date | 1 January, 2013 |
Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1% |
Lock In | No Lock-in |
TurnOver | 55.36% |
Health | 100% |
Holdings | Weight% | No. of Shares (4M) | 1M Change |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd | 14.9% | 0% | |
Cipla Ltd | 8.5% | 0% | |
Dr Reddy's Laboratories Ltd | 7.5% | 6.3% | |
Divi's Laboratories Ltd | 7.5% | 0% | |
Torrent Pharmaceuticals Ltd | 6.5% | -7.5% |
Fund | Jun'22 | May'22 | Apr'22 |
---|---|---|---|
No of Holdings | 30 | 30 | 31 |
Top 5 Company Concentration | 44.4% | 44.4% | 44.3% |
Company having highest exposure | Sun Pharmaceuticals Industries Ltd (13.8%) | Sun Pharmaceuticals Industries Ltd (13.9%) | Sun Pharmaceuticals Industries Ltd (14%) |
No of Sectors | 2 | 2 | 2 |
Top 5 Sectors Concentration | 100% | 100% | 100% |
Sector having highest exposure | Health (99%) | Health (98.3%) | Health (98.7%) |
Top Growth Drivers | 1M Return |
---|---|
Fortis Healthcare Ltd | 18% |
Sun Pharmaceuticals Industries Ltd | 13.7% |
Divis Laboratories Ltd | 5.3% |
Top Losers | 1M Return |
---|---|
Gland Pharma Ltd | -14.8% |
Dr Reddys Laboratories Ltd | -6.7% |
Zydus Lifesciences Ltd | -4% |
Scheme | Annualised Returns(3Y) | Category Returns(3Y) |
---|---|---|
Nippon India Large Cap Fund - Direct Plan - Growth Plan | 19.99% | 17.88% |
Nippon India Multi Cap Fund - Direct Plan - Growth | 22.66% | 22.18% |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 27.84% | 25.78% |
Scheme | Annualised Returns(3Y) | Category Returns(3Y) |
---|---|---|
Nippon India Liquid Fund Direct Plan Growth Plan | 4.15% | 3.22% |
Nippon India Small Cap Fund - Direct Plan - Growth Plan | 36.86% | 32.45% |
Nippon India Multi Cap Fund - Direct Plan - Growth | 22.66% | 22.18% |
UTI Healthcare Fund-Growth Option- Direct
26.15% (3 Yrs)
DSP Healthcare Fund Direct Growth
30.82% (3 Yrs)
Mirae Asset Healthcare Fund Direct Growth
32.07% (3 Yrs)
SBI Healthcare Opportunities Fund Direct Growth
27.14% (3 Yrs)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
28.03% (3 Yrs)
Frequently Asked Questions